163 related articles for article (PubMed ID: 18794053)
1. The association of C (-260)-->T polymorphism in CD14 promoter and Chlamydia pneumoniae infection in ischemic stroke patients.
Lin TM; Chen CH; Wu HL; Wang CH; Chen YL; Eng HL
Am J Clin Pathol; 2008 Oct; 130(4):595-601. PubMed ID: 18794053
[TBL] [Abstract][Full Text] [Related]
2. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection.
Eng HL; Chen CH; Kuo CC; Wu JS; Wang CH; Lin TM
J Infect Dis; 2003 Jul; 188(1):90-7. PubMed ID: 12825176
[TBL] [Abstract][Full Text] [Related]
3. Chronic infections and genetic factors in the development of ischemic stroke.
Kis Z; Sas K; Gyulai Z; Treso B; Petrovay F; Kapusinszky B; Csire M; Endresz V; Burian K; Mandi Y; Vecsei L; Gonczol E
New Microbiol; 2007 Jul; 30(3):213-20. PubMed ID: 17802898
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke.
Park MH; Min JY; Koh SB; Kim BJ; Park MK; Park KW; Lee DH
Thromb Res; 2006; 118(6):671-7. PubMed ID: 16386288
[TBL] [Abstract][Full Text] [Related]
5. CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes.
Rupp J; Goepel W; Kramme E; Jahn J; Solbach W; Maass M
Genes Immun; 2004 Aug; 5(5):435-8. PubMed ID: 15175649
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population.
Lichy C; Meiser H; Grond-Ginsbach C; Buggle F; Dörfer C; Grau A
J Neurol; 2002 Jul; 249(7):821-3. PubMed ID: 12140663
[TBL] [Abstract][Full Text] [Related]
7. Role of CD14 promoter polymorphisms in Helicobacter pylori infection--related gastric carcinoma.
Zhao D; Sun T; Zhang X; Guo Y; Yu D; Yang M; Tan W; Wang G; Lin D
Clin Cancer Res; 2007 Apr; 13(8):2362-8. PubMed ID: 17438094
[TBL] [Abstract][Full Text] [Related]
8. Effects of CD14, TLR2, TLR4, LPB, and IL-6 gene polymorphisms on Chlamydia pneumoniae growth in human macrophages in vitro.
Poikonen K; Lajunen T; Silvennoinen-Kassinen S; Leinonen M; Saikku P
Scand J Immunol; 2009 Jul; 70(1):34-9. PubMed ID: 19522765
[TBL] [Abstract][Full Text] [Related]
9. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
Am J Cardiol; 2006 Nov; 98(9):1182-4. PubMed ID: 17056323
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in the promoter region of the CD14 gene and susceptibility to Brucellosis.
Haidari M; Hajilooi M; Rezazadeh M; Rafiei A; Alavi SA; Keramat F
Immunol Invest; 2006; 35(2):239-45. PubMed ID: 16698680
[TBL] [Abstract][Full Text] [Related]
11. Association of the C-399T promoter polymorphism of neuropeptide Y with susceptibility to ischemic stroke.
Kim NS; Oh SM; Ko MM; Cha MH; Kang BK; Bang OS
Clin Biochem; 2009 Nov; 42(16-17):1699-704. PubMed ID: 19619519
[TBL] [Abstract][Full Text] [Related]
12. Serologic markers for Chlamydia pneumoniae in asthma.
Hahn DL; Peeling RW; Dillon E; McDonald R; Saikku P
Ann Allergy Asthma Immunol; 2000 Feb; 84(2):227-33. PubMed ID: 10719781
[TBL] [Abstract][Full Text] [Related]
13. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production.
Eng HL; Wang CH; Chen CH; Chou MH; Cheng CT; Lin TM
Genes Immun; 2004 Aug; 5(5):426-30. PubMed ID: 15164100
[TBL] [Abstract][Full Text] [Related]
14. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
Griga T; Klein W; Epplen JT; Hebler U; Stachon A; May B
Hepatogastroenterology; 2005; 52(63):808-11. PubMed ID: 15966209
[TBL] [Abstract][Full Text] [Related]
15. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes.
Arroyo-Espliguero R; El-Sharnouby K; Vázquez-Rey E; Kalidas K; Jeffery S; Kaski JC
Int J Cardiol; 2005 Feb; 98(2):307-12. PubMed ID: 15686783
[TBL] [Abstract][Full Text] [Related]
16. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease.
Griga T; Wilkens C; Schmiegel W; Folwaczny C; Hagedorn M; Duerig N; Epplen J; Klein W
Eur J Med Res; 2005 May; 10(5):183-6. PubMed ID: 15946916
[TBL] [Abstract][Full Text] [Related]
17. Relevance of the genetic polymorphism of NOD1 in Chlamydia pneumoniae seropositive stroke patients.
Tiszlavicz Z; Somogyvári F; Kocsis AK; Szolnoki Z; Sztriha LK; Kis Z; Vécsei L; Mándi Y
Eur J Neurol; 2009 Nov; 16(11):1224-9. PubMed ID: 19538217
[TBL] [Abstract][Full Text] [Related]
18. The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients.
Heesen M; Bloemeke B; Schade U; Obertacke U; Majetschak M
Intensive Care Med; 2002 Aug; 28(8):1161-3. PubMed ID: 12185442
[TBL] [Abstract][Full Text] [Related]
19. Effects of CD14-159 C/T polymorphism on CD14 expression and the balance between proinflammatory and anti-inflammatory cytokines in whole blood culture.
Lin J; Yao YM; Yu Y; Chai JK; Huang ZH; Dong N; Sheng ZY
Shock; 2007 Aug; 28(2):148-53. PubMed ID: 17515856
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population.
Banerjee I; Gupta V; Ahmed T; Faizaan M; Agarwal P; Ganesh S
Brain Res Bull; 2008 Jan; 75(1):158-65. PubMed ID: 18158110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
